134 related articles for article (PubMed ID: 34006586)
21. Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.
Du Y; Wang Y; Zhang F; Wu W; Wang W; Li H; Xia S; Liu H
Tumour Biol; 2015 Nov; 36(11):8839-44. PubMed ID: 26069102
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma.
Zeng XC; Liu FQ; Yan R; Yi HM; Zhang T; Wang GY; Li Y; Jiang N
Mol Cancer; 2014 Dec; 13():261. PubMed ID: 25491321
[TBL] [Abstract][Full Text] [Related]
23. Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradation.
Zhang L; Zhou F; Li Y; Drabsch Y; Zhang J; van Dam H; ten Dijke P
J Biol Chem; 2012 Aug; 287(36):30701-10. PubMed ID: 22730322
[TBL] [Abstract][Full Text] [Related]
24. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
25. WNT/β-catenin signaling inhibits CBP-mediated RelA acetylation and expression of proinflammatory NF-κB target genes.
Ma B; Fey M; Hottiger MO
J Cell Sci; 2015 Jul; 128(14):2430-6. PubMed ID: 26021349
[TBL] [Abstract][Full Text] [Related]
26. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
27. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
28. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus.
Topol L; Chen W; Song H; Day TF; Yang Y
J Biol Chem; 2009 Jan; 284(5):3323-3333. PubMed ID: 19047045
[TBL] [Abstract][Full Text] [Related]
29. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
[TBL] [Abstract][Full Text] [Related]
30. Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance.
Mukherjee N; Bhattacharya N; Alam N; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2012 Feb; 103(2):210-20. PubMed ID: 22026417
[TBL] [Abstract][Full Text] [Related]
31. Silencing mediator for retinoid and thyroid hormone receptor and nuclear receptor corepressor attenuate transcriptional activation by the beta-catenin-TCF4 complex.
Song LN; Gelmann EP
J Biol Chem; 2008 Sep; 283(38):25988-99. PubMed ID: 18632669
[TBL] [Abstract][Full Text] [Related]
32. Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation.
Huang J; Cardamone MD; Johnson HE; Neault M; Chan M; Floyd ZE; Mallette FA; Perissi V
J Biol Chem; 2015 Jul; 290(31):19044-54. PubMed ID: 26070566
[TBL] [Abstract][Full Text] [Related]
33. YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer.
Chen C; Zhu D; Zhang H; Han C; Xue G; Zhu T; Luo J; Kong L
Cell Death Dis; 2018 May; 9(6):591. PubMed ID: 29789528
[TBL] [Abstract][Full Text] [Related]
34. The WNT/β-catenin signaling pathway and expression of survival promoting genes in luteinized granulosa cells: endometriosis as a paradigm for a dysregulated apoptosis pathway.
Sanchez AM; Viganò P; Quattrone F; Pagliardini L; Papaleo E; Candiani M; Panina-Bordignon P
Fertil Steril; 2014 Jun; 101(6):1688-96. PubMed ID: 24661731
[TBL] [Abstract][Full Text] [Related]
35. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
[TBL] [Abstract][Full Text] [Related]
36. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
[TBL] [Abstract][Full Text] [Related]
37. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
38. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin.
Grossmann TN; Yeh JT; Bowman BR; Chu Q; Moellering RE; Verdine GL
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17942-7. PubMed ID: 23071338
[TBL] [Abstract][Full Text] [Related]
40. TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.
Pray BA; Youssef Y; Alinari L
Exp Hematol; 2022 Dec; 116():18-25. PubMed ID: 36206873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
